Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Venetoclax is approved for adult patients with chronic lymphocytic leukemia and acute myeloid leukemia. Expanding its use to the pediatric population is currently under investigation, but more robust data are needed. We retrospectively analyzed the safety and efficacy of venetoclax in children/AYA w...

Full description

Bibliographic Details
Main Authors: Amber Gibson, Adriana Trabal, David McCall, Sajad Khazal, Laurie Toepfer, Donna H. Bell, Michael Roth, Kris M. Mahadeo, Cesar Nunez, Nicholas J. Short, Courtney DiNardo, Marina Konopleva, Ghayas C. Issa, Farhad Ravandi, Nitin Jain, Gautam Borthakur, Hagop M. Kantarjian, Elias Jabbour, Branko Cuglievan
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cancers
Subjects:
acute lymphoblastic leukemia
lymphoblastic lymphoma
venetoclax
Bcl-2 inhibitor
early precursor T-cell
Online Access:https://www.mdpi.com/2072-6694/14/1/150

Internet

https://www.mdpi.com/2072-6694/14/1/150

Similar Items